Shuichi Nojiri

763 total citations
10 papers, 586 citations indexed

About

Shuichi Nojiri is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Shuichi Nojiri has authored 10 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Immunology and 2 papers in Surgery. Recurrent topics in Shuichi Nojiri's work include T-cell and Retrovirus Studies (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Colorectal Cancer Screening and Detection (2 papers). Shuichi Nojiri is often cited by papers focused on T-cell and Retrovirus Studies (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Colorectal Cancer Screening and Detection (2 papers). Shuichi Nojiri collaborates with scholars based in Japan, Netherlands and United Kingdom. Shuichi Nojiri's co-authors include Tetsuji Takayama, Junji Kato, Yasuo Takahashi, Yoshiro Niitsu, Sumio Sakamaki, Hirotsugu Miyake, Shinichi Katsuki, Katsuhisa Kogawa, Motoh Ohi and Hiroyuki Nagashima and has published in prestigious journals such as New England Journal of Medicine, Clinical Cancer Research and European Journal of Gastroenterology & Hepatology.

In The Last Decade

Shuichi Nojiri

8 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuichi Nojiri Japan 5 336 242 147 98 91 10 586
Motoh Ohi Japan 5 426 1.3× 305 1.3× 260 1.8× 94 1.0× 137 1.5× 6 779
Franco Armelao Italy 15 309 0.9× 229 0.9× 199 1.4× 63 0.6× 130 1.4× 28 891
Robyn T. Bilinski United States 8 130 0.4× 154 0.6× 232 1.6× 103 1.1× 32 0.4× 11 547
Giulia Piazzi Italy 17 175 0.5× 103 0.4× 463 3.1× 86 0.9× 99 1.1× 29 873
Steven Goldschmid United States 6 146 0.4× 68 0.3× 234 1.6× 132 1.3× 63 0.7× 6 504
Mike F. Müller Germany 9 181 0.5× 173 0.7× 258 1.8× 36 0.4× 52 0.6× 12 592
Valentina Aristarco Italy 12 240 0.7× 106 0.4× 308 2.1× 33 0.3× 78 0.9× 31 588
Andrea Markkula Sweden 13 197 0.6× 42 0.2× 159 1.1× 77 0.8× 80 0.9× 25 501
Hong Seok Choi South Korea 11 101 0.3× 91 0.4× 156 1.1× 36 0.4× 66 0.7× 24 484

Countries citing papers authored by Shuichi Nojiri

Since Specialization
Citations

This map shows the geographic impact of Shuichi Nojiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuichi Nojiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuichi Nojiri more than expected).

Fields of papers citing papers by Shuichi Nojiri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuichi Nojiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuichi Nojiri. The network helps show where Shuichi Nojiri may publish in the future.

Co-authorship network of co-authors of Shuichi Nojiri

This figure shows the co-authorship network connecting the top 25 collaborators of Shuichi Nojiri. A scholar is included among the top collaborators of Shuichi Nojiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuichi Nojiri. Shuichi Nojiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kuroda, Hiroyuki, Masahiro Yoshida, Michiko Yamada, et al.. (2014). [Combined modality therapy for a patient with primary adrenal lymphoma].. PubMed. 41(4). 509–12. 1 indexed citations
2.
Hoki, Toshifumi, Hiroyuki Kuroda, Yutaka Okagawa, et al.. (2012). [Chronic hepatitis C presenting with hepatic involvement by chronic lymphocytic leukemia responding to polyethylene glycol interferon-α-2b].. PubMed. 39(10). 1551–4. 1 indexed citations
3.
Takayama, Tetsuji, Hiroyuki Nagashima, Masahiro Maeda, et al.. (2011). Randomized Double-Blind Trial of Sulindac and Etodolac to Eradicate Aberrant Crypt Foci and to Prevent Sporadic Colorectal Polyps. Clinical Cancer Research. 17(11). 3803–3811. 52 indexed citations
4.
Fujita, Miri, Takayuki Matsuki, Hiroshi Takahashi, et al.. (2003). An unusual case of primary effusion lymphoma in a HIV‐negative patient not pathogenetically associated with HHV8. European Journal Of Haematology. 71(1). 62–67. 42 indexed citations
5.
Takayama, Tetsuji, Shinichi Katsuki, Yasuo Takahashi, et al.. (1998). Aberrant Crypt Foci of the Colon as Precursors of Adenoma and Cancer. New England Journal of Medicine. 339(18). 1277–1284. 461 indexed citations
6.
Takayama, Tetsuji, Shinichi Katsuki, Yasuo Takahashi, et al.. (1998). Aberrant crypt foci of the colon as precursors of adenoma and cancer. European Journal of Gastroenterology & Hepatology. 10(12). 1063–1063. 24 indexed citations
7.
Nojiri, Shuichi, Yasuhiro Nagamachi, Kazuhiko Koike, et al.. (1994). Postinfantile giant cell hepatitis accompanied by hypereosinophilia.. Kanzo. 35(12). 864–869.
8.
Sakamaki, Sumio, Yutaka Kohgo, Shuichi Nojiri, et al.. (1992). Effect of Krestin<sup>R</sup> (PSK) on the Induction of IL-2 Activated Killer Cells. Japanese Journal of Clinical Oncology. 22(2). 79–83. 4 indexed citations
9.
Kohgo, Yutaka, Sumio Sakamaki, Shuichi Nojiri, et al.. (1989). Generation of lymphokine activated killer cells in a new high density dialyzing culture apparatus. Cytotechnology. 2(1). 49–57.
10.
Kohgo, Yutaka, et al.. (1984). The Mechanism of Inhibition of IL-2 Production in Human Cancer Bearers. Medical Entomology and Zoology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026